Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

NCT00895739 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Nonmalignant Neoplasm

Interventions

BIOLOGICAL: alemtuzumab
DRUG: cyclosporine

Sponsor

Federico II University